FR2137560A1 - - Google Patents

Info

Publication number
FR2137560A1
FR2137560A1 FR7216146A FR7216146A FR2137560A1 FR 2137560 A1 FR2137560 A1 FR 2137560A1 FR 7216146 A FR7216146 A FR 7216146A FR 7216146 A FR7216146 A FR 7216146A FR 2137560 A1 FR2137560 A1 FR 2137560A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7216146A
Other languages
French (fr)
Other versions
FR2137560B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ENDO LAB
Original Assignee
ENDO LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ENDO LAB filed Critical ENDO LAB
Publication of FR2137560A1 publication Critical patent/FR2137560A1/fr
Application granted granted Critical
Publication of FR2137560B1 publication Critical patent/FR2137560B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7216146A 1971-05-07 1972-05-05 Expired FR2137560B1 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14140771A 1971-05-07 1971-05-07

Publications (2)

Publication Number Publication Date
FR2137560A1 true FR2137560A1 (OSRAM) 1972-12-29
FR2137560B1 FR2137560B1 (OSRAM) 1975-10-31

Family

ID=22495561

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7216146A Expired FR2137560B1 (OSRAM) 1971-05-07 1972-05-05

Country Status (3)

Country Link
DE (1) DE2222039A1 (OSRAM)
FR (1) FR2137560B1 (OSRAM)
GB (1) GB1390772A (OSRAM)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0074105A1 (en) * 1981-09-08 1983-03-16 Michael Richard Magruder Nalbuphine-narcotic oral analgesic composition and method of producing analgesia
EP0144243A1 (en) * 1983-12-06 1985-06-12 Reckitt And Colman Products Limited Analgesic compositions
WO1993002707A1 (de) * 1991-08-06 1993-02-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue antidiarrhoica
US5339928A (en) * 1991-09-30 1994-08-23 Bendix Europe Services Techniques Friction member provided with a wear indicator device and disk-brake fitted with such member

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
CN1204890C (zh) 1997-12-22 2005-06-08 欧罗赛铁克股份有限公司 防止阿片样物质滥用的方法
ES2412409T3 (es) 1997-12-22 2013-07-11 Euro-Celtique S.A. Forma farmacéutica para dosificación oral que comprende una combinación de un agonista opiáceo y un antagonista opiáceo
SI1299104T1 (sl) 2000-02-08 2009-10-31 Euro Celtique Sa Oralne formulacije opioidnih agonistov, varne pred zlorabo
US6716449B2 (en) 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
US20030065002A1 (en) 2001-05-11 2003-04-03 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
AU2002316738B2 (en) * 2001-07-18 2009-01-08 Euro-Celtique S.A. Pharmaceutical combinations of oxycodone and naloxone
US7914818B2 (en) 2001-08-06 2011-03-29 Purdue Pharma L.P. Opioid agonist formulations with releasable and sequestered antagonist
WO2003013433A2 (en) 2001-08-06 2003-02-20 Euro-Celtique S.A. Sequestered antagonist formulations
ES2320748T5 (es) * 2002-04-05 2017-02-20 Euro-Celtique S.A. Matriz para la liberación sostenida, invariable e independiente de compuestos activos
EP2422773A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
MY135852A (en) 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1810678A1 (de) * 2006-01-19 2007-07-25 Holger Lars Hermann Verwendung einer Kombination von Morphin und Naloxon zur Drogensubstitution
ES2636657T3 (es) 2006-06-19 2017-10-06 Alpharma Pharmaceuticals Llc Composición farmacéutica
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
UY32487A (es) 2009-03-10 2010-06-30 Euro Celtique Sa Composiciones farmacéuticas de liberación inmediata comprendiendo oxicodona y naloxona
UA116567C2 (uk) 2013-07-23 2018-04-10 Євро-Селтік С.А. Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0074105A1 (en) * 1981-09-08 1983-03-16 Michael Richard Magruder Nalbuphine-narcotic oral analgesic composition and method of producing analgesia
EP0144243A1 (en) * 1983-12-06 1985-06-12 Reckitt And Colman Products Limited Analgesic compositions
WO1993002707A1 (de) * 1991-08-06 1993-02-18 Byk Gulden Lomberg Chemische Fabrik Gmbh Neue antidiarrhoica
US5339928A (en) * 1991-09-30 1994-08-23 Bendix Europe Services Techniques Friction member provided with a wear indicator device and disk-brake fitted with such member

Also Published As

Publication number Publication date
FR2137560B1 (OSRAM) 1975-10-31
GB1390772A (en) 1975-04-16
DE2222039A1 (de) 1972-11-23

Similar Documents

Publication Publication Date Title
ATA136472A (OSRAM)
AR196074A1 (OSRAM)
AU2658571A (OSRAM)
AU2691671A (OSRAM)
AU2941471A (OSRAM)
AU2485671A (OSRAM)
AU2894671A (OSRAM)
AU2742671A (OSRAM)
AU2726271A (OSRAM)
AU2952271A (OSRAM)
AU2684071A (OSRAM)
AU3005371A (OSRAM)
AU2564071A (OSRAM)
AU2473671A (OSRAM)
AU2836771A (OSRAM)
AU3038671A (OSRAM)
AU2503871A (OSRAM)
AU3025871A (OSRAM)
AU2577671A (OSRAM)
AU2588771A (OSRAM)
AU2654071A (OSRAM)
AU2927871A (OSRAM)
AU2669471A (OSRAM)
AU2456871A (OSRAM)
AU2684171A (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse